|
MechanismHIV p17 matrix protein inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismImmunostimulants |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Medestea Internazionale Srl
0 Patents (Medical) associated with Medestea Internazionale Srl
100 Deals associated with Medestea Internazionale Srl
100 Translational Medicine associated with Medestea Internazionale Srl